BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer
CompletedOBSERVATIONAL
Enrollment
63
Participants
Timeline
Start Date
October 15, 2012
Primary Completion Date
October 11, 2018
Study Completion Date
October 11, 2018
Conditions
Ovarian Cancer, Peritoneal Neoplasms
Trial Locations (1)
6020
Tiroler Landeskrankenanstalten Ges.M.B.H.; Abt. Für Gynäkologie, Innsbruck
All Listed Sponsors
lead
Hoffmann-La Roche
INDUSTRY
NCT01788995 - BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer | Biotech Hunter | Biotech Hunter